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Human African trypanosomiasis (HAT),
or sleeping sickness, is caused by two
subspecies of the protozoan parasite Try-
panosoma brucei (T.b.) and transmitted
through tsetse flies (Glossina sp.). T.b.
gambiense occurs from West to Central sub-
Sahara Africa, while T.b. rhodesiense is
endemic in East sub-Sahara Africa. Other
closely related taxa (T.b. brucei, T. evansi, T.
equiperdum, T. congolense, T. vivax) cause
animal African trypanosomiases in domes-
tic animals like cattle, horse, camel, goat,
sheep, and buffalo in Africa, Latin Amer-
ica, Europe, and Asia [1].
Approximately 10,000 sleeping sickness
patients are diagnosed and treated each
year [2]. This is only a fraction of those
carrying this lethal infection since (i) the
population at risk lives mainly in remote
areas outside the action radius of health
centres or mobile teams, and (ii) the
diagnostic tests suffer from limited sensi-
tivity [3,4].
There is a consensus to (i) only treat
patients with confirmed diagnosis, i.e., in
whom the parasite has been demonstrated,
except in particular situations, and (ii) to
examine the cerebrospinal fluid (CSF) for
white blood cell counts and the presence of
trypanosomes in order to decide which
drugs to administer. To determine wheth-
er a patient is cured, examination of CSF
is repeated each semester for up to 2 years
[4].
In T.b. gambiense sleeping sickness, gen-
eral low parasite loads necessitate the use
of concentration techniques to reveal
infection. Capillary tube centrifugation
(CTC, WOO) [5], quantitative buffy coat
(QBC) [6], and mini anion exchange
centrifugation technique (mAECT) [7]
are applied on blood. mAECT is the most
sensitive method for trypanosome detec-
tion in blood and is based on a purification
technique first described by Lanham et al.
and later adapted for diagnosis of sleeping
sickness and of animal infections with T.
brucei and T. evansi [7–10]. In mAECT,
trypanosomes are separated from 350 ml
of blood by anion exchange chromatogra-
phy on diethylaminoethyl cellulose
(DEAE). Eluted trypanosomes are then
concentrated by low speed centrifugation
followed by direct microscopic examina-
tion of the sediment in a transparent
collector tube. The large volume of blood
examined allows detection of fewer than
50 trypanosomes/ml. For sensitive detec-
tion of trypanosomes in CSF, single and
double centrifugation (DC) and modified
single centrifugation (MSC) are applied,
with MSC being easier to perform and at
least as sensitive as DC [11].
For several years, mAECT was pro-
duced at the Projet de Recherches Clin-
iques sur la Trypanosomiase (PRCT) in
Daloa, Co ˆte d’Ivoire, with financial sup-
port from the World Health Organization
(WHO), and then for some time at Institut
Pierre Richet (IPR) in Bouake ´, Co ˆte
d’Ivoire. The PRCT model is still pro-
duced on demand in this country (B.
Miezan, personal commmunication). Sev-
eral attempts to establish a production unit
elsewhere were discontinued.
At the request of the Belgian Technical
Cooperation (BTC) for the Programme
National de Lutte contre la Trypanoso-
miase Humaine Africaine (PNLTHA) in
the Democratic Republic of the Congo
(DRC), the Institute of Tropical Medicine
(ITM, Belgium) and the Institut National
de Recherche Biome ´dicale (INRB, DRC)
developed a modified version of the
mAECT. With financial support from
the Belgian Directorate General for De-
velopment Cooperation and WHO, pro-
duction at INRB started in 2003. At the
end of 2005, production stopped since raw
material for the 9-mm diameter glass
collector tube was not commercially avail-
able anymore.
From 2006 on, with support from the
Foundation for Innovative New Diagnos-
tics (FIND), the column rack, microscope
viewing chamber, and collector tube were
redesigned. Important advantages of the
new collector tube and the viewing
chamber are their robustness and the fact
that microscopic examination of the sed-
iment is possible without mounting the tip
of the collector tube under water
(Figures 1–3). Improvements were made
to the packing trays (Figure S1), filter
material (Figure S2), sterilisation proce-
dure, and instruction leaflets. In addition,
the production infrastructure at INRB and
the quality control system were upgraded.
Actually, quality control is performed
internally at INRB and externally at
ITM before a batch is released. Detailed
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were written and are collated in an
mAECT handbook that can be found on
the FIND Web site [12].
In 2007, a comparison between the first
model of mAECT produced at INRB and
the PRCT model was carried out at the
Centre International de Recherche-De ´vel-
oppement sur l’Elevage en zone Sub-
humide (CIRDES) in Bobo-Dioulasso,
Burkina Faso, on 198 columns of each
model. Columns received 350 ml of human
blood containing on average 35 T.b.
gambiense trypanosomes (100 trypanosomes
per ml of blood). The time to run a column
was recorded and trypanosomes in each
collector tube were counted by two inde-
pendent observers. Averages were com-
pared using paired t-test and showed a
significantly shorter run time for the INRB
than the PRCT model (29 and 42 min,
respectively, p,0.0001), which is explained
by the fact that in the INRB model, no
glucose should be added before applying
the blood. In addition, more trypanosomes
were recovered by the INRB than by the
PRCT model (5.85 and 4.92, respectively,
p,0.005). After changing the filter material
in 2008, the second INRB model was
compared with the previous one by the
same CIRDES experts on 195 columns of
each type. The second model runs faster
than the first (21 and 33 min, respectively,
p,0.0001) and showed higher average
trypanosome numbers (4.43 and 1.76,
respectively, p,0.0001). The lower average
trypanosome numbers counted with the
first model compared to the previous
comparison is probably caused by the still
unexplained fact that the number of
recovered trypanosomes seems to be blood
donor dependent.
Figure 1. Column rack with mounted columns and trypanosomes being eluted from the blood in the collector tubes.
doi:10.1371/journal.pntd.0000471.g001
Figure 2. Collector tube mounted in the mAECT viewing chamber under the microscope.
doi:10.1371/journal.pntd.0000471.g002
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cardboard boxes. One contains 20
mAECT columns best stored at 4uC–
8uC, although tests are stable for 12
months at a maximum of 37uC. The other
contains 20 collector tubes, 20 centrifuga-
tion tubes, 20 transfer pipettes, and the
instruction leaflet (available in English,
French, and Portuguese). Specifications of
the kit are given in Box 1.
In the original MSC test on CSF
described by Miezan et al., 2-ml glass
pasteur pipettes are used as collector tubes
and are examined after mounting the tip
under water [11]. With its 4 ml of volume
and no need for mounting under water,
the new plastic mAECT collector tube is
expected to increase the sensitivity and the
robustness of MSC on CSF, although a
formal comparative test still has to be
performed. An MSC kit for 20 tests with
instruction leaflets in English, French, or
Portuguese is now also available from
INRB. Specifications of the kit are given
in Box 2.
mAECT and MSC kits can be ordered
at INRB. For prices and delivery condi-
tions, contact mumbadieudonne@yahoo.
fr, url: . Additional information is available
on the FIND Web site at http://www.
finddiagnostics.org.
The mAECT and MSC tests are used
by diverse organisations and institutes in
their HAT control activities and in clinical
investigations. Current clients are the Na-
tional HAT Control Programme in DRC,
the World Health Organization, Institute of
Tropical Medicine Antwerp, Swiss Tropical
Institute, Drugs for Neglected Diseases
Initiative, Me ´decins Sans Frontie `res, Med-
ische Missie Samenwerking, Institut de
Recherche au De ´veloppement, and Orga-
nisation de Coordination pour la Lutte
contre les Endemies en Afrique Centrale.
Supporting Information
FigureS1 BoxwithTenmAECTColumns
Found at: doi:10.1371/journal.pntd.
0000471.s001 (0.26 MB PDF)
Figure S2 Elution of T. brucei Parasites
from Blood with the mAECT Columns
Found at: doi:10.1371/journal.pntd.
0000471.s002 (0.27 MB PDF)
References
1. Bu ¨scher P, Lejon V (2004) Diagnosis of human
African trypanosomiasis. In: Maudlin I, Holmes P,
Miles MA, eds.The trypanosomiases. Oxfordshire:
CABI Publishing. pp 203–218.
2. Simarro PP, Jannin J, Cattand P (2008) Elimi-
nating human African trypanosomiasis: where do
we stand and what comes next? Plos Med 5: e55.
doi:10.1371/journal.pmed.0050055.
3. Robays J, Bilengue MMC, Van der Stuyft P,
Boelaert M (2004) The effectiveness of active
population screening and treatment from sleeping
sickness control in the Democratic republic of
Congo. Trop Med Int Health 9: 542–550.
4. Chappuis F, Loutan L, Simarro P, Lejon V,
Bu ¨scher P (2005) Options for the field diagnosis of
human African trypanosomiasis. Clin Microbiol
Rev 18: 133–146.
5. Woo PTK (1970) The haematocrit centrifuge
technique for the diagnosis of African trypanoso-
miasis. Acta Trop 27: 384–386.
6. Bailey JW, Smith DH (1994) The quantitative
buffy coat for the diagnosis of trypanosomes.
Trop Doct 24: 54–56.
7. Lumsden WHR, Kimber CD, Evans DA, Doig SJ
(1979) Trypanosoma brucei: miniature anion-ex-
change centrifugation technique for detection of
low parasitaemias: adaptation for field use.
Trans R Soc Trop Med Hyg 73: 312–317.
8. Mie ´zan TW, Meda AH, Doua F, Cattand P
(1994) Evaluation des techniques parasitologiques
utilise ´es dans le diagnostic de la trypanosomose
humaine a ` Trypanosoma gambiense en Co ˆte d’Ivoire.
Bull Soc Pathol Exot Fil 87: 101–104.
9. Lanham SM, Godfrey DG (1970) Isolation of
salivarian trypanosomes from man and other
mammals using DEAE-cellulose. Exp Parasitol
28: 521–534.
10. Gutierrez C, Corbera JA, Doreste F, Bu ¨scher P
(2004) Use of the miniature anion exchange
centrifugation technique to isolate Trypanosoma
evansi from goats. Ann N Y Acad Sci 1026:
149–151.
11. Mie ´zan TW, Meda AH, Doua F, Dje ´ NN,
Lejon V, Bu ¨scher P (2000) Single centrifugation
of cerebrospinal fluid in a sealed pasteur pipette
for simple, rapid and sensitive detection of
trypanosomes. Trans R Soc Trop Med Hyg 94:
293.
12. Foundation for Innovative New Diagnostics (2009)
mAECT standard operating procedures. Avail-
able: http://www.finddiagnostics.org/programs/
hat/find_activities/maect_sop/index.html. Ac-
cessed 29 October 2009.
Figure 3. Detail of collector tube tip.
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Box 1. Three Advantages
and Three Disadvantages
for the New mAECT Model
Advantages
1. Analytical sensitivity ,50 trypano-
somes per ml of blood at only J3
per test.
2. Robustness and no need to
mount collector tube in water for
microscopic examination.
3. Applicable in field conditions.
Disadvantages
1. Need for specific material and
centrifuge.
2. Limited stability since the glucose
is now incorporated in the column
buffer (maximum 1 year at 37uC).
3. Qualified personnel needed to
perform the test.
Box 2. Three Advantages
and Three Disadvantages
for the New MSC Model
Advantages
1. Analytical sensitivity ,2 trypano-
somes per ml of CSF at only J0.5
per test.
2. Short test time (,15 minutes).
3. Few manipulations.
Disadvantages
1. Need for specific material and
centrifuge.
2. CSF sediment cannot be recuper-
ated for other tests.
3. Interference of CSF white blood
cells possible, especially at high
cell counts.
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